Syra Health Reports Second Consecutive Profitable Quarter and Revenue Growth
Syra Health sustained profitability in Q2 2026, reporting $2.4 million in revenue, a 23% year-over-year increase. The company improved its gross margin to 44.5%.
Syra Health maintained its profitability in the second quarter of 2026, marking its second consecutive profitable period. The company reported a net income of $250,242, a significant improvement from a net loss of $63,596 in the prior-year period.
Revenue for Q2 2026 saw a 23% increase compared to the same period last year, reaching $2.4 million. Additionally, the company's gross margin improved to 44.5%, indicating enhanced operational efficiency and cost management.
This sustained profitability follows Syra Health's first profitable quarter in Q1 2026. The company's financial performance highlights a positive trend in revenue growth and improved margins within the technology sector.
Syra Health's leadership stated that the company remains focused on executing its growth strategy and achieving its long-term financial objectives.